CN104862336B - A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP - Google Patents
A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP Download PDFInfo
- Publication number
- CN104862336B CN104862336B CN201510211260.8A CN201510211260A CN104862336B CN 104862336 B CN104862336 B CN 104862336B CN 201510211260 A CN201510211260 A CN 201510211260A CN 104862336 B CN104862336 B CN 104862336B
- Authority
- CN
- China
- Prior art keywords
- ntcp
- hbv
- mouse
- people
- hntcp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of expression hepatitis B receptor --- construction methods of the mouse model of people NTCP.The present invention takes the transgenosis mode of hydrodynamic coefficients to be conducted into Mice Body by the micro-loop carrier of building carrier NTCP gene, makes one NTCP gene and expresses in mouse liver.The defect that this model will overcome existing experiment mice to be unable to natural infection HBV, building up one kind has hepatitis B functional receptor, can support HBV In vivo infection and the mouse model with normal immunological function.So as to really, comprehensively reflect clinical hepatitis B generation, development and chronicity process, for the pathogenic mechanism for further studying HBV, mechanism of action of the pathological change and body immune system of body in viral infection resisting and immune pathogenic course provides ideal animal model after HBV infection.
Description
Technical field
The invention belongs to animal model preparation technical fields, and in particular to a kind of expression hepatitis B receptor --- people NTCP
Mouse model construction method.
Background technique
Hepatitis type B virus (hepatitis B virus, HBV) infection is the weight that human health is influenced in global range
Big problem.The chronic progressive liver inflammation lesion as caused by HBV infection, usually development is cirrhosis, liver cancer and eventually leads to
It is dead.According to World Health Organization, global about 2,000,000,000 people had infected HBV, were at present HBV chronic infection there are about 3.5 hundred million people
Person, the risk that these people progress to cirrhosis, hepatic failure or liver cancer are very high.30% cirrhosis and more than 50% in global range
Liver cancer be as caused by HBV infection, every year because caused by HBV infection death toll be about 1,000,000-200 ten thousand.HBV infection
Caused liver diseases are still a great public health problem urgently to be resolved.All the time, China is all HBV infection
District occurred frequently, hepatitis B disease incidence is integrally in rising trend, and based on chronic HBV infection.Data shows: China is existing slow
Property HBV infection person is about 93,000,000, and wherein chronic hepatitis B patient about 20,000,000, accounts for the 1/5 of Patients with Chronic HBV Infection
By force.Guangdong is always the hotspot of virus hepatitis, and Monitoring on epidemic situation of infectious diseases information is shown: Guangdong Province's hepatitis B surface antigen is taken
Band rate is 11. 10%, belongs to the high Endemic Area of hepatitis B, especially based on chronic adult's hepatitis B infection.It can be seen that China
The prevention and treatment task of hepatitis B especially chronic hepatitis B is still very arduous.
Patients with Chronic HBV Infection and chronic hepatitis B patient are the main infections of HBV due to carrying a large amount of HBV
Source.China all puts into a large amount of funds and manpower physical resources for the treatment of such crowd every year and prevents HBV in crowd
Be propagated further.However, still lacking the means of effective treatment chronic HBV infection at present.One important reason is HBV
The mechanism of chronic infection fails clear so far.And lack suitable animal model for a long time, seriously hinder the research of HBV into
Exhibition.
Mankind HBV belongs to Hepadnaviridae, there is stronger species specificity, therefore setting up can be widely applied dynamic
Object model not a duck soup.Lower infection people of HBV natural conditions, non-human primates (such as chimpanzee) and tree shrew.Chimp model
Because its volume it is larger, it is at high cost and by ethics constraint etc. limit its application;And tree shrew model is then due to its infection effect
Rate is low, is only capable of leading to of short duration low-grade infection, virus titer is very low, and is difficult to promote and apply.Researcher also once establishes HBV
The small animal model of relevant other hepadnavirus carries out correlative study, such as duck hepatitis-B model, woodchuck hepatitis mould
Type, ground squirrel hepatitis model etc., but these models have in pharmacokinetics and immunology genetic background with the mankind it is very big not
Together, therefore all it can not become the ideal model of people HBV correlative study.
In recent years, since heredity and immune background understand, are easy to the advantages that raising, mouse is gradually by the pass of researcher
Note becomes the optimal selection of building HBV animal model.Researcher also establishes people-mouse liver chimera HBV mouse model, base
Because of HBV transfected mouse model and HBV transgene mouse model etc..But due to constantly multiple in vivo after HBV infection human body
System, infection cycle liver cell, and thus cause a series of immune responses of body, or escape the monitoring of immune system and clear
Remove, thus in vivo long-term existence and lead to the chronicity of hepatitis B, therefore to HBV pathogenic mechanism have one it is clear bright
True understanding, and then effective treatment means are searched out, there is an urgent need to one kind intact immune system by researcher, and can
People HBV is simulated in the animal model of the course of infection of human liver.Since mouse is not naturally by HBV infection, and built at present
Vertical hepatitis B mouse model fails that mouse liver cell is overcome to infect this problem of HBV, thus is also unable to satisfy HBV research to dynamic
The requirement of object model.Such as, people-mouse liver chimera HBV mouse model is able to achieve the infection duplication process of HBV, but this model is
Mouse based on immune deficiency, therefore the immune response of Study Mouse can not be used for, and manufacture difficulty it is big, it is at high cost, at
Power is low, it is difficult to be widely popularized utilization.Gene HBV transfected mouse model, in preparation process, HBV enters in Mice Body and can cause
The immune response of host generates the cellular immunity and humoral immunity for being directed to HBV, however due to carrier and the antigen of HBV itself
Property and HBV are unable to infecting mouse liver cell, cause HBV of short duration can only secrete, are not suitable for chronic HBV infection and chronic
The research of type hepatitis.Although secretion HBV virus and antigen that current existing HBV transgenic mice can be stable, without each
It is transfected or is transplanted, but since model is not by by the approach foundation of HBV infection, can not be used to carry out HBV entrance
Infected body and HBV are in the intracorporal distribution research of machine;On the other hand, existing HBV transgenic mice is viral to HBV at present
Antigen is in immune tolerance state, and body cannot generate the immune response to HBV, does not also generate hepatitis B lesion.Moreover, turning
The acquisition of DNA murine needs expensive microinjection equipment and complicated operation, very time and effort consuming.The above reason results in
The missing that can be used for the animal model of chronic HBV infection and the nonimmune tolerance of chronic hepatitis B, objectively limits to chronic
Pathogenesis of hepatitis B, immunopathogenesis, therapeutic agent and the correlative study of immunization therapy.
How to establish it is a kind of it is cheap, easy to operate, have intact immune system, HBV can be simulated human liver's
The small animal model of course of infection becomes critical issue urgently to be resolved needed for HBV research to meet.
The portal that HBV enters liver cell is viral receptor.Studies have shown that HBV has stringent host susceptibility and thermophilic
Hepatocellular.The specific peptide fragment of antigen that infection early stage is present in HBV outer membrane is identified and is combined with specific receptors on liver cell, is mediated
Cell entry cell starts the replicative cycle of HBV.Scholars in succession report can active hepatitis type B virus receptor,
Such as polyerized human serum albumin, interior connection element II, Apolipoprotein H, IL-6, Glyceraldehyde 3-phosphate dehydrogenase, neutral metalloprotease
Enzyme, human liver cell adds element etc., but does not determine the receptor to play a decisive role in HBV infection yet until the end of the year 2012.
Recently, the newest research achievement of China scientist confirm sodium ion taurocholate cotransport polypeptide (Na+/
Taurocholate Cotransporting Polypeptide, NTCP) be hepatitis type B virus critical functionality receptor.
NTCP wide expression is most important sodium ion dependence taurocholate absorption system in liver cell in liver cell basolateral membrane,
It is most important bile acid adsorbent system in liver, plays an important role in intestines liver circulation.The region Pre-S1 of HBV is special
Identify NTCP, the infected liver cell in conjunction with it.Studies have shown that the NTCP by inhibiting the endogenous generation of liver cell, makes NTCP's
Expression reduces, and reduces the content of the NTCP in liver cell, as a result considerably reduces sense of the HBV to people and tree shrew liver cell
Dye.If NTCP is reduced in the HepaRG cell of enabled infection HBV, these cell infections HBV can be reduced.Usually it cannot infect
Huh7 the and HepG2 cultured cell in vitro system of hepatitis B generates corresponding protein after importing NTCP gene, these cells are just
It can be infected by HBV.It studies while showing: although NTCP has in multiple species such as mouse, rat, tree shrew, chimpanzee, people
Expression, and have higher homology, but the difference of a few amino acid in particular combination domain leads to different plant species
NTCP is identified to HBV and the greatest differences of binding ability, this is also narrow one of the reason of HBV host range.Machin
NTCP generally can not in conjunction with hepatitis B, as long as but experiment show to be mutated the minimum region of its NTCP the preceding paragraph, be allowed to by people
The corresponding amino acid substitution of NTCP can become effective HBV receptor, mediate infection of the HBV to machin liver cell.For
This, people NTCP is considered as the hepatitis type B virus receptor of the most potential quality found so far, causes the very big of scholars
Interest and concern, and be greatly prized by, this research achievement also brings preciousness simultaneously to establish ideal HBV infection model
Opportunity.
But have not yet to see the mouse that people NTCP is transferred to building expression people NTCP in Mice Body by report so far in the prior art
The method of model, reason may be due to: 1.NTCP is just proved to be hepatitis B functional receptor recently, and there has been no correlation models
The report that mouse builds up;2. the importing form and introduction method of foreign gene directly influence external source base in animal model preparation
Because of the presence and expression in animal.It is intended in different animal model preparation process by groping.It is existing for this problem
Technology does not have effective solution scheme also.
Summary of the invention
The technical problem to be solved by the present invention is to lack the mouse model for expressing people NTCP in the prior art to overcome, especially
It is a lack of the defect for continuing, stablizing the mouse model of expression people NTCP, provides a kind of expression hepatitis B receptor --- people
The construction method of the mouse model of NTCP.
The purpose of the present invention is achieved by the following technical programs:
A kind of construction method of mouse model that expressing people NTCP, includes the following steps:
S1. people's NTCP gene eucaryon expression frame is obtained through PCR amplification from plasmid pcDNA6-hNTCP;
S2., people's NTCP gene eucaryon expression frame is inserted into attB and attP of plasmid ZY781 by molecule clone technology
Between point, the micro-loop parental plasmid ZY781-CMV-hNTCP of carrier's NTCP gene eucaryon expression frame is obtained;
S3. micro-loop parental plasmid ZY781-CMV-hNTCP is transferred in E.coli ZYCY10P3S2T competence, through card
That chloramphenicol resistance screening positive clone, gained recombinant plasmid obtain carrier after arabinose induction recombinase Ф C31 effect
The minicircle dna (pMC-CMV-hNTCP) of NTCP eukaryotic expression cassette;
S4. it by minicircle dna (pMC-CMV-hNTCP) by hydrodynamic coefficients method, imports in Mice Body and obtains gene transfection
Mouse, gene transfect mouse through PCR, can be used as model after groupization detection and the detection of related biological index and ground with to related
Study carefully.
The acquisition condition of the minicircle dna of carrier NTCP eukaryotic expression cassette described in S3 are as follows: by 300 μ l micro-loop induction mother liquors
50ml is inoculated with to contain in the TB culture solution of 50 μ g/ml kanamycins, 37 DEG C, 250 rpm/min cultivate 12~18h after, to
Isometric induction liquid is added in culture solution, 32 DEG C, 250 rpm/min, 5 h of culture receive bacterium, extract minicircle dna;The induction
Liquid contains 20% L-arabinose of the LB culture solution of 50 ml, the NaOH solution of 2 ml 1N and 300 μ l.
Preferably, the micro-loop induces with mother liquor the preparation method comprises the following steps: parental plasmid ZY781-CMV-hNTCP is convertedE.coliZYCY10P3S2T competence, the single positive colony of picking are inoculated into TB culture solution, 37 DEG C, 250 rpm/min, training
Support 15~18h to OD600When value about 4~5, it can be used as induction with mother liquor and carry out induction generation minicircle dna.
The hydrodynamic coefficients method and step are as follows: the ICR mouse for choosing 6~8 weeks, 26~28g of weight, by 15 μ g carriers
The minicircle dna of NTCP eukaryotic expression cassette is dissolved in 2.5ml physiological saline, and Mice Body is injected into 5~8s through mouse tail vein
It is interior.The present invention also does control group and blank control group test respectively simultaneously with pcDNA6 and physiological saline.
People NTCP is transferred in Mice Body and makes its expression, people if the present invention imagines on the Research foundation of forefathers
NTCP can combine people HBV, to enable mouse liver cell by HBV infection, while this mouse also has and normally exempts from
Epidemic disease system, therefore the defect that this mouse model will can overcome existing mouse to be unable to natural infection hepatitis B are realized maximum
The simulation clinic hepatitis B of degree occurs, develops and lapse to process, for the course of infection for studying hepatitis B, finds new medicine target
Point and the immunotherapy for exploring hepatitis B provide ideal model.And how people NTCP to be successfully transferred in Mice Body, and make its
Continue in Mice Body, stablize expression, is the Important Problems to be solved.The present invention compares carrier type, channel genes by optimization
Method obtains a kind of mouse model that is sustainable, stablizing expression people NTCP.Selected carrier is micro-loop carrier ZY781;Micro-loop
Carrier ZY781 is transformed again by Shenzhen Institutes of Advanced Technology, Chinese Academy of Science's Chen Zhi English etc., micro-loop carrier ZY781 in addition to
Except characteristic possessed by general micro-loop carrier, micro-loop carrier ZY781 one step can also be obtained from bacterium, not needed further
Purifying, yield are up to 99%.Selected method of gene introduction is hydrodynamic coefficients technology, and hydrodynamic coefficients technology is a kind of letter
Single effective living gene rotaring dyeing technology is equivalent to the injection scale of construction that Mice Body weighs about 8% using injection in the short time, causes
Solution pressure and capacity are more than mouse systolic pressure and cardiac output, so that plasmid is gathered in inferior caval vein, and straight through inferior caval vein
It taps into and is contacted into the rich blood vessel being attached thereto, the liver with expansible structure with liver cell, so as to avoid Plasmid DNA warp
Blood circulation and degraded by nuclease, transfection efficiency is substantially increased, to realize foreign gene in the intracorporal efficient table of mouse
It reaches.Moreover, hydrodynamic coefficients method has good liver targeting, intracorporal gene is imported with the method and is expressed in liver
Level is high by 100 compared in other organs~and 1 000 times, 40~90% may be up to the transfection efficiency of internal liver cell, so especially suitable
For hepatitis virus experimental animal model and its relevant functional study.
The beneficial effects of the present invention are:
The present invention by building carrier NTCP gene micro-loop carrier, take the transgenosis mode of hydrodynamic coefficients by its
It imports in Mice Body, makes one NTCP gene in liver expression.This model will overcome experiment mice to be unable to lacking for natural infection HBV
It falls into, building up one kind has hepatitis B functional receptor, can support HBV In vivo infection and the mouse with normal immunological function
Model.It is the cause of further research HBV so as to really, comprehensively reflect clinical hepatitis B generation, development and chronicity process
Interpretation of the cause, onset and process of an illness system, the pathological change of body and body immune system are in viral infection resisting and immune pathogenic course after HBV infection
Mechanism of action provides ideal animal model.The foundation of this model lacks the blank of such animal model by filling up both at home and abroad,
Keep relevant research means more abundant, also provides more advanced appraisement system for the research and development of anti-hbv drug and technology is flat
Platform.
Preferably animal model should be repeatable, even can be standardized.The present invention expresses hepatitis B in preparation
Virus receptor --- it, will be in people's NTCP channel genes Mice Body in addition to consideration when the mouse model of people NTCP, it is often more important that
What consider that mode is taken to keep people's NTCP gene to continue in Mice Body, stablize expression.Therefore, the present invention passes through optimization ratio
A kind of mouse model that is sustainable, stablizing expression people NTCP is obtained compared with carrier type, method of gene introduction.
Figure of description
Fig. 1 pcDNA6-hNTCP plasmid map.
Fig. 2 .ZY781 empty carrier map.
Fig. 3 ZY781-CMV-hNTCP micro-loop parental plasmid map.
Fig. 4 pMC-hNTCP micro-loop carrier for expression of eukaryon map.
The flow chart of the mouse model of Fig. 5 building expression hNTCP.
Fig. 6 .hNTCP gene eucaryon expression frame PCR amplification electrophoretic identification.
Fig. 7 .ZY781-CMV-hNTCP BglII-SalI double digestion qualification result figure.
Fig. 8 .pMC-hNTCP and ZY781-CMV-hNTCP NdeI single endonuclease digestion result figure.
Fig. 9 gene transfects mouse PCR qualification result figure.
Figure 10 gene transfects murine liver tissue hNTCP immunohistochemistry qualification result figure.
Specific embodiment
Present invention be described in more detail with specific embodiment with reference to the accompanying drawings of the specification.Unless stated otherwise, this hair
The bright reagent used, equipment is the art conventional reagent and equipment.
PcDNA6-hNTCP plasmid is given by Beijing Life Sciences Institute Li Wenhui researcher, structure chart such as Fig. 1
It is shown;E.coliZYCY10P3S2T and ZY781 empty carrier is given by Shenzhen Xianjin Technology Academe of Chinese Academy of Sciences professor Chen Zhiying,
ZY781 empty carrier structure chart is as shown in Figure 2.The present invention constructs expression hepatitis B receptor --- the stream of the mouse model of people NTCP
Journey figure is as shown in Figure 5.
Embodiment 1
People's NTCP gene eucaryon expression frame is obtained from pcDNA6-hNTCP using round pcr and introduces BglII- SalI
Double enzyme site is then inserted between the site attB and attP of plasmid zy781, induces recombinase Ф C31 through arabinose
The minicircle dna (pMC-CMV-hNTCP) of carrier's NTCP eukaryotic expression cassette is obtained after effect.
S1. the acquisition of people NTCP gene eucaryon expression frame: with pcDNA6-hNTCP plasmid (plasmid sequence such as SEQ ID NO:
Shown in 1) it is template, the forward direction (band BglII restriction enzyme site) and reverse primer (band of design amplification people NTCP gene eucaryon expression frame
SalI restriction enzyme site):
Forward primer F:5 '-GAAGATCTCCCGATCCCCTAT -3 '
Reverse primer R:5 '-ACGCGTCGACCCATAGAGCCCACC -3 '
PCR reaction system and response procedures are as follows:
Reaction condition:
PCR after reaction, recycles PCR product, obtains the CMV-hNTCP-BGHpolyA genetic fragment of 2260bp, CMV-
HNTCP-BGHpolyA genetic fragment is through BglII(NEB) and SalI(NEB) double digestion obtain CMV-hNTCP-BGHpolyA
(2248bp), i.e. hNTCP gene eucaryon expression frame.The identification of PCR result agarose gel electrophoresis is as shown in Figure 6.
S2. by between the site attB and attP of people's NTCP gene eucaryon expression frame insertion plasmid ZY781, carrier is obtained
The micro-loop parental plasmid ZY781-CMV-NTCP of NTCP gene order, sequence is as shown in SEQ ID NO:2, by micro-loop parent's matter
Grain ZY781-CMV-NTCP is transformed intoE.coliIn ZYCY10P3S2T competence, make through arabinose induction recombinase Ф C31
The minicircle dna of carrier's NTCP eukaryotic expression cassette is obtained after.Specific steps are as follows:
Enzyme used in digestion: hNTCP gene eucaryon expression frame and ZY781 empty carrier use BglII(NEB) and SalI(NEB)
Carry out double digestion.
Endonuclease reaction system and condition: 37 DEG C of reaction temperature, digestion 15h.Endonuclease reaction system is as follows:
Digestion products purification process: gel extraction is purified using plastic recovery kit (TaKaRa, DV805A).
Digestion products connection: using connection kit (NEB, M2200S), linked system is as follows:
The 1.4 μ l of PCR product (50ug/ μ l) of BglII-SalI double digestion;
The 1.67 μ l of ZY781 (30ug/ μ l) of BglII-SalI double digestion;
ddH2O 6.93µl ;
2x quick ligation buffer 10µl;
1 μ l of Quick T4 ligase.
After having configured solution by the above linked system, after thoroughly mixing after 25 DEG C of reaction 5min, cooled on ice, it is used for
Conversion is saved in -20 DEG C.
The product being successfully connected is ZY781-CMV-hNTCP plasmid, i.e. micro-loop parental plasmid;ZY781-CMV-hNTCP
The plasmid figure spectrogram of plasmid is as shown in Figure 3.Whether successful connection can be first by the conversion of next step and kanamycin resistance screening
Step determines, further confirms that subsequently through digestion identification.
Conversion: it is prepared using Calcium Chloride MethodE.coliZYCY10P3S2T competent cell, by the ZY781-CMV- of building
HNTCP plasmid is transferred toE.coliIn ZYCY10P3S2T competence, tentatively sieved by the kalamycin resistance that parental plasmid carries
Choosing obtains positive colony, extracts plasmid, BglII-SalI double digestion electroresis appraisal.Electroresis appraisal result such as Fig. 7.(foreign gene
2248bp, carrier 4066bp)
S3. the preparation of the minicircle dna pMC-CMV-hNTCP of carrier NTCP eukaryotic expression cassette.Arabinose induction recombination
The minicircle dna of carrier's NTCP eukaryotic expression cassette is obtained after enzyme Ф C31 effect.Specific step is as follows: the conversion of micro-loop parental plasmid
After competence, screening positive clone, positive colony is inoculated into TB culture solution, 37 DEG C, 250 rpm/min, cultivates 12~18h
To OD600Value obtains micro-loop induction mother liquor when being about 4~5, can carry out the micro-loop of induction carrier NTCP gene eucaryon expression frame
The generation of plasmid.The generation step of the micro-loop plasmid of carrier's NTCP gene eucaryon expression frame are as follows: 300 μ l micro-loops are induced and are used
Mother liquor is inoculated in the TB culture solution containing kanamycins (50 μ g/ml) of 50 ml, 37 DEG C, 250 rpm/min culture
After 18h, added into culture solution same volume induction liquid (the NaOH solution of the LB of 50 ml and 2 ml 1N and
300 μ l, 20% L-arabinose), 32 DEG C, 250 rpm/min cultivate 5 h, bacterium are received, using going toxin plasmid extracts kit
(E.Z.N.A. Endotoxin Free Plasmid Isolation System, D6915) extracts carrier NTCP gene
The micro-loop Plasmid DNA (pMC-hNTCP) of eukaryotic expression cassette, nucleotides sequence are classified as shown in SEQ ID NO:3.Through NdeI single endonuclease digestion
Identification.(parental plasmid cuts out 4411bp, two band of 1903bp, and micro-loop cuts out mono- band of 2315bp) electroresis appraisal result such as Fig. 8
It is shown.The map of hNTCP gene micro-loop carrier for expression of eukaryon pMC-hNTCP is as shown in Figure 4.
Micro-loop Production conditions of the present invention are that inventor summarizes to obtain by a large amount of exploratory experiment, only upper
Under the conditions of stating, a large amount of recombination micro-loop carrier can just be prepared, and the purity of carrier is very high, without miscellaneous carrier such as parent's matter
The pollution of grain.It is not that amount vector cannot be guaranteed if change condition, is exactly that the purity of carrier not can guarantee, only
Above-mentioned condition could meet simultaneously.
Embodiment 3
Also carry out Mediated Human NTCP gene using the carrier for expression of eukaryon of this field routine prepares animal model to the present invention simultaneously,
Such as recombinant eukaryotic expression plasmid pcDNA6-hNTCP is prepared into table also by hydrodynamic coefficients technological sourcing ICR Mice Body
The mouse model of intelligent's NTCP gene.But as a result, it has been found that: when with conventional carrier for expression of eukaryon come Mediated Human NTCP gene, system
Standby mouse model is unable to continuous expression people's NTCP gene, is not able to satisfy the quality requirement of animal model.And it uses in the present invention
The plasmid ZY781 and engineering bacteria referred toE.coliZYCY10P3S2T prepares the micro-loop carrier for expression of eukaryon of carrier NTCP,
Optimization induction micro-loop Production conditions, a final step obtain the micro-loop carrier for expression of eukaryon of carrier NTCP, reduce step, remove from and mentioning
Process is taken, cost is saved.
Embodiment 4 is with the mouse of the micro-loop pMC-hNTCP preparation expression people NTCP of carrier's NTCP gene eucaryon expression frame
Model.
1, hydrodynamic coefficients technology preparation people NTCP gene transfects mouse: the ICR mouse of selection 6~8 weeks, and weight 26~
28g.It is divided into three groups: experimental group, control group, blank control group.Experimental group is by the minicircle dna of carrier's NTCP eukaryotic expression cassette
15 μ g are dissolved in 2.5ml physiological saline, and pcDNA615 μ g is dissolved in 2.5ml physiological saline by control group, and blank control group is
2.5ml physiological saline is injected into Mice Body in 5-8s through mouse tail vein.
2, PCR screening and identification gene transfects mouse: respectively at the 1st, 14 day, every group took 2 mouse to take hepatic tissue, mentioned respectively
Hepatic tissue DNA is taken to carry out PCR detection.
Forward primer F:5 '-CCTGGTGGCACAGTATGG -3 '
Reverse primer R:5 '-TTTGGATTTGAGGACGAT -3 '
PCR reaction system and response procedures are as follows:
Reaction condition:
Above-mentioned PCR product is subjected to 1.5%(w/v) agarose gel electrophoresis, as a result as shown in Fig. 9, the positive is one
The specific band of 346bp shows that hNTCP gene is successfully transferred in Mice Body.
3. immunohistochemistry identifies that gene transfects mouse: in the 14th day, every group took 2 mouse to take hepatic tissue, set 10% formaldehyde
12~14h is fixed, makes histotomy according to a conventional method, immunohistochemistry detects the expression of hNTCP in hepatic tissue, as a result sees figure
10.(Anti-SLC10A1 antibody antibody 1:200 dilution, Sigma, HPA042727).
SEQUENCE LISTING
<110>Hospital No.458 of P.L.A.
<120>a kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP
<130>
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 6074
<212> DNA
<213>pcDNA6-hNTCP plasmid sequence
<400> 1
gacggatcgg gagatctccc gatcccctat ggtgcactct cagtacaatc tgctctgatg 60
ccgcatagtt aagccagtat ctgctccctg cttgtgtgtt ggaggtcgct gagtagtgcg 120
cgagcaaaat ttaagctaca acaaggcaag gcttgaccga caattgcatg aagaatctgc 180
ttagggttag gcgttttgcg ctgcttcgcg atgtacgggc cagatatacg cgttgacatt 240
gattattgac tagttattaa tagtaatcaa ttacggggtc attagttcat agcccatata 300
tggagttccg cgttacataa cttacggtaa atggcccgcc tggctgaccg cccaacgacc 360
cccgcccatt gacgtcaata atgacgtatg ttcccatagt aacgccaata gggactttcc 420
attgacgtca atgggtggag tatttacggt aaactgccca cttggcagta catcaagtgt 480
atcatatgcc aagtacgccc cctattgacg tcaatgacgg taaatggccc gcctggcatt 540
atgcccagta catgacctta tgggactttc ctacttggca gtacatctac gtattagtca 600
tcgctattac catggtgatg cggttttggc agtacatcaa tgggcgtgga tagcggtttg 660
actcacgggg atttccaagt ctccacccca ttgacgtcaa tgggagtttg ttttggcacc 720
aaaatcaacg ggactttcca aaatgtcgta acaactccgc cccattgacg caaatgggcg 780
gtaggcgtgt acggtgggag gtctatataa gcagagctct ctggctaact agagaaccca 840
ctgcttactg gcttatcgaa attaatacga ctcactatag ggagacccaa gctggctagc 900
gccaccatgg aggcccacaa cgcgtctgcc ccattcaact tcaccctgcc acccaacttt 960
ggcaagcgcc ccacagacct ggcactgagc gtcatcctgg tgttcatgtt gttcttcatc 1020
atgctctcgc tgggctgcac catggagttc agcaagatca aggctcactt atggaagcct 1080
aaagggctgg ccatcgccct ggtggcacag tatggcatca tgcccctcac ggcctttgtg 1140
ctgggcaagg tcttccggct gaagaacatt gaggcactgg ccatcttggt ctgtggctgc 1200
tcacctggag ggaacctgtc caatgtcttc agtctggcca tgaaggggga catgaacctc 1260
agcattgtga tgaccacctg ctccaccttc tgtgcccttg gcatgatgcc tctcctcctg 1320
tacatctact ccagggggat ctatgatggg gacctgaagg acaaggtgcc ctataaaggc 1380
atcgtgatat cactggtcct ggttctcatt ccttgcacca tagggatcgt cctcaaatcc 1440
aaacggccac aatacatgcg ctatgtcatc aagggaggga tgatcatcat tctcttgtgc 1500
agtgtggccg tcacagttct ctctgccatc aatgtgggga agagcatcat gtttgccatg 1560
acaccactct tgattgccac ctcctccctg atgcctttta ttggctttct gctgggttat 1620
gttctctctg ctctcttctg cctcaatgga cggtgcagac gcactgtcag catggagact 1680
ggatgccaaa atgtccaact ctgttccacc atcctcaatg tggcctttcc acctgaagtc 1740
attggaccac ttttcttctt tcccctcctc tacatgattt tccagcttgg agaagggctt 1800
ctcctcattg ccatattttg gtgctatgag aaattcaaga ctcccaagga taaaacaaaa 1860
atgatctaca cagctgccac aactgaagaa acaattccag gagctctggg aaatggcacc 1920
tacaaagggg aggactgctc cccttgcaca gccaccgaga cctcccaggt ggcgcccgct 1980
tagaccggtc atcatcacca tcaccattga gtttaaaccc gctgatcagc ctcgactgtg 2040
ccttctagtt gccagccatc tgttgtttgc ccctcccccg tgccttcctt gaccctggaa 2100
ggtgccactc ccactgtcct ttcctaataa aatgaggaaa ttgcatcgca ttgtctgagt 2160
aggtgtcatt ctattctggg gggtggggtg gggcaggaca gcaaggggga ggattgggaa 2220
gacaatagca ggcatgctgg ggatgcggtg ggctctatgg cttctgaggc ggaaagaacc 2280
agctggggct ctagggggta tccccacgcg ccctgtagcg gcgcattaag cgcggcgggt 2340
gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg ccctagcgcc cgctcctttc 2400
gctttcttcc cttcctttct cgccacgttc gccggctttc cccgtcaagc tctaaatcgg 2460
gggctccctt tagggttccg atttagtgct ttacggcacc tcgaccccaa aaaacttgat 2520
tagggtgatg gttcacgtag tgggccatcg ccctgataga cggtttttcg ccctttgacg 2580
ttggagtcca cgttctttaa tagtggactc ttgttccaaa ctggaacaac actcaaccct 2640
atctcggtct attcttttga tttataaggg attttgccga tttcggccta ttggttaaaa 2700
aatgagctga tttaacaaaa atttaacgcg aattaattct gtggaatgtg tgtcagttag 2760
ggtgtggaaa gtccccaggc tccccagcag gcagaagtat gcaaagcatg catctcaatt 2820
agtcagcaac caggtgtgga aagtccccag gctccccagc aggcagaagt atgcaaagca 2880
tgcatctcaa ttagtcagca accatagtcc cgcccctaac tccgcccatc ccgcccctaa 2940
ctccgcccag ttccgcccat tctccgcccc atggctgact aatttttttt atttatgcag 3000
aggccgaggc cgcctctgcc tctgagctat tccagaagta gtgaggaggc ttttttggag 3060
gcctaggctt ttgcaaaaag ctcccgggag cttgtatatc cattttcgga tctgatcagc 3120
acgtgttgac aattaatcat cggcatagta tatcggcata gtataatacg acaaggtgag 3180
gaactaaacc atggccaagc ctttgtctca agaagaatcc accctcattg aaagagcaac 3240
ggctacaatc aacagcatcc ccatctctga agactacagc gtcgccagcg cagctctctc 3300
tagcgacggc cgcatcttca ctggtgtcaa tgtatatcat tttactgggg gaccttgtgc 3360
agaactcgtg gtgctgggca ctgctgctgc tgcggcagct ggcaacctga cttgtatcgt 3420
cgcgatcgga aatgagaaca ggggcatctt gagcccctgc ggacggtgcc gacaggtgct 3480
tctcgatctg catcctggga tcaaagccat agtgaaggac agtgatggac agccgacggc 3540
agttgggatt cgtgaattgc tgccctctgg ttatgtgtgg gagggctaag cacttcgtgg 3600
ccgaggagca ggactgacac gtgctacgag atttcgattc caccgccgcc ttctatgaaa 3660
ggttgggctt cggaatcgtt ttccgggacg ccggctggat gatcctccag cgcggggatc 3720
tcatgctgga gttcttcgcc caccccaact tgtttattgc agcttataat ggttacaaat 3780
aaagcaatag catcacaaat ttcacaaata aagcattttt ttcactgcat tctagttgtg 3840
gtttgtccaa actcatcaat gtatcttatc atgtctgtat accgtcgacc tctagctaga 3900
gcttggcgta atcatggtca tagctgtttc ctgtgtgaaa ttgttatccg ctcacaattc 3960
cacacaacat acgagccgga agcataaagt gtaaagcctg gggtgcctaa tgagtgagct 4020
aactcacatt aattgcgttg cgctcactgc ccgctttcca gtcgggaaac ctgtcgtgcc 4080
agctgcatta atgaatcggc caacgcgcgg ggagaggcgg tttgcgtatt gggcgctctt 4140
ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg gctgcggcga gcggtatcag 4200
ctcactcaaa ggcggtaata cggttatcca cagaatcagg ggataacgca ggaaagaaca 4260
tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt 4320
tccataggct ccgcccccct gacgagcatc acaaaaatcg acgctcaagt cagaggtggc 4380
gaaacccgac aggactataa agataccagg cgtttccccc tggaagctcc ctcgtgcgct 4440
ctcctgttcc gaccctgccg cttaccggat acctgtccgc ctttctccct tcgggaagcg 4500
tggcgctttc tcatagctca cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca 4560
agctgggctg tgtgcacgaa ccccccgttc agcccgaccg ctgcgcctta tccggtaact 4620
atcgtcttga gtccaacccg gtaagacacg acttatcgcc actggcagca gccactggta 4680
acaggattag cagagcgagg tatgtaggcg gtgctacaga gttcttgaag tggtggccta 4740
actacggcta cactagaaga acagtatttg gtatctgcgc tctgctgaag ccagttacct 4800
tcggaaaaag agttggtagc tcttgatccg gcaaacaaac caccgctggt agcggtggtt 4860
tttttgtttg caagcagcag attacgcgca gaaaaaaagg atctcaagaa gatcctttga 4920
tcttttctac ggggtctgac gctcagtgga acgaaaactc acgttaaggg attttggtca 4980
tgagattatc aaaaaggatc ttcacctaga tccttttaaa ttaaaaatga agttttaaat 5040
caatctaaag tatatatgag taaacttggt ctgacagtta ccaatgctta atcagtgagg 5100
cacctatctc agcgatctgt ctatttcgtt catccatagt tgcctgactc cccgtcgtgt 5160
agataactac gatacgggag ggcttaccat ctggccccag tgctgcaatg ataccgcgag 5220
acccacgctc accggctcca gatttatcag caataaacca gccagccgga agggccgagc 5280
gcagaagtgg tcctgcaact ttatccgcct ccatccagtc tattaattgt tgccgggaag 5340
ctagagtaag tagttcgcca gttaatagtt tgcgcaacgt tgttgccatt gctacaggca 5400
tcgtggtgtc acgctcgtcg tttggtatgg cttcattcag ctccggttcc caacgatcaa 5460
ggcgagttac atgatccccc atgttgtgca aaaaagcggt tagctccttc ggtcctccga 5520
tcgttgtcag aagtaagttg gccgcagtgt tatcactcat ggttatggca gcactgcata 5580
attctcttac tgtcatgcca tccgtaagat gcttttctgt gactggtgag tactcaacca 5640
agtcattctg agaatagtgt atgcggcgac cgagttgctc ttgcccggcg tcaatacggg 5700
ataataccgc gccacatagc agaactttaa aagtgctcat cattggaaaa cgttcttcgg 5760
ggcgaaaact ctcaaggatc ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg 5820
cacccaactg atcttcagca tcttttactt tcaccagcgt ttctgggtga gcaaaaacag 5880
gaaggcaaaa tgccgcaaaa aagggaataa gggcgacacg gaaatgttga atactcatac 5940
tcttcctttt tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca 6000
tatttgaatg tatttagaaa aataaacaaa taggggttcc gcgcacattt ccccgaaaag 6060
tgccacctga cgtc 6074
<210> 2
<211> 6314
<212> DNA
<213>zy781-cmv-hntcp micro-loop parental plasmid sequence
<400> 2
acattaccct gttatcccta gatgacatta ccctgttatc ccagatgaca ttaccctgtt 60
atccctagat gacattaccc tgttatccct agatgacatt taccctgtta tccctagatg 120
acattaccct gttatcccag atgacattac cctgttatcc ctagatacat taccctgtta 180
tcccagatga cataccctgt tatccctaga tgacattacc ctgttatccc agatgacatt 240
accctgttat ccctagatac attaccctgt tatcccagat gacataccct gttatcccta 300
gatgacatta ccctgttatc ccagatgaca ttaccctgtt atccctagat acattaccct 360
gttatcccag atgacatacc ctgttatccc tagatgacat taccctgtta tcccagatga 420
cattaccctg ttatccctag atacattacc ctgttatccc agatgacata ccctgttatc 480
cctagatgac attaccctgt tatcccagat gacattaccc tgttatccct agatacatta 540
ccctgttatc ccagatgaca taccctgtta tccctagatg acattaccct gttatcccag 600
atgacattac cctgttatcc ctagatacat taccctgtta tcccagatga cataccctgt 660
tatccctaga tgacattacc ctgttatccc agataaactc aatgatgatg atgatgatgg 720
tcgagactca gcggccgcgg tgccagggcg tgcccttggg ctccccgggc gcgactagtg 780
aattcagatc tcccgatccc ctatggtgca ctctcagtac aatctgctct gatgccgcat 840
agttaagcca gtatctgctc cctgcttgtg tgttggaggt cgctgagtag tgcgcgagca 900
aaatttaagc tacaacaagg caaggcttga ccgacaattg catgaagaat ctgcttaggg 960
ttaggcgttt tgcgctgctt cgcgatgtac gggccagata tacgcgttga cattgattat 1020
tgactagtta ttaatagtaa tcaattacgg ggtcattagt tcatagccca tatatggagt 1080
tccgcgttac ataacttacg gtaaatggcc cgcctggctg accgcccaac gacccccgcc 1140
cattgacgtc aataatgacg tatgttccca tagtaacgcc aatagggact ttccattgac 1200
gtcaatgggt ggagtattta cggtaaactg cccacttggc agtacatcaa gtgtatcata 1260
tgccaagtac gccccctatt gacgtcaatg acggtaaatg gcccgcctgg cattatgccc 1320
agtacatgac cttatgggac tttcctactt ggcagtacat ctacgtatta gtcatcgcta 1380
ttaccatggt gatgcggttt tggcagtaca tcaatgggcg tggatagcgg tttgactcac 1440
ggggatttcc aagtctccac cccattgacg tcaatgggag tttgttttgg caccaaaatc 1500
aacgggactt tccaaaatgt cgtaacaact ccgccccatt gacgcaaatg ggcggtaggc 1560
gtgtacggtg ggaggtctat ataagcagag ctctctggct aactagagaa cccactgctt 1620
actggcttat cgaaattaat acgactcact atagggagac ccaagctggc tagcgccacc 1680
atggaggccc acaacgcgtc tgccccattc aacttcaccc tgccacccaa ctttggcaag 1740
cgccccacag acctggcact gagcgtcatc ctggtgttca tgttgttctt catcatgctc 1800
tcgctgggct gcaccatgga gttcagcaag atcaaggctc actttggaag cctaaagggc 1860
tggccatcgc cctggtggca cagtatggca tcatgcccct cacggccttt gtgctgggca 1920
aggtcttccg gctgaagaac attgaggcac tggccatctt ggtctgtggc tgctcacctg 1980
gagggaacct gtccaatgtc ttcagtctgg ccatgaaggg ggacatgaac ctcagcattg 2040
tgatgaccac ctgctccacc ttctgtgccc ttggcatgat gcctctcctc ctgtacatct 2100
actccagggg gatctatgat ggggacctga aggacaaggt gccctataaa ggcatcgtga 2160
tatcactggt cctggttctc attccttgca ccatagggat cgtcctcaaa tccaaacggc 2220
cacaatacat gcgctatgtc atcaagggag ggatgatcat cattctcttg tgcagtgtgg 2280
ccgtcacagt tctctctgcc atcaatgtgg ggaagagcat catgtttgcc atgacaccac 2340
tcttgattgc cacctcctcc ctgatgcctt ttattggctt tctgctgggt tatgttctct 2400
ctgctctctt ctgcctcaat ggacggtgca gacgcactgt cagcatggag actggatgcc 2460
aaaatgtcca actctgttcc accatcctca atgtggcctt tccacctgaa gtcattggac 2520
cacttttctt ctttcccctc ctctacatga ttttccagct tggagaaggg cttctcctca 2580
ttgccatatt ttggtgctat gagaaattca agactcccaa ggataaaaca aaaatgatct 2640
acacagctgc cacaactgaa gaaacaattc caggagctct gggaaatggc acctacaaag 2700
gggaggactg ctccccttgc acagccaccg agacctccca ggtggcgccc gcttagaccg 2760
gtcatcatca ccatcaccat tgagtttaaa cccgctgatc agcctcgact gtgccttcta 2820
gttgccagcc atctgttgtt tgcccctccc ccgtgccttc cttgaccctg gaaggtgcca 2880
ctcccactgt cctttcctaa taaaatgagg aaattgcatc gcattgtctg agtaggtgtc 2940
attctattct ggggggtggg gtggggcagg acagcaaggg ggaggattgg gaagacaata 3000
gcaggcatgc tggggatgcg gtgggctcta tgggtcgacc catgggggcc cgccccaact 3060
ggggtaacct ttgagttctc tcagttgggg gtaatcagca tcatgatgtg gtaccacatc 3120
atgatgctga ttataagaat gcggccgcca cactctagtg gatctcgagt taataattca 3180
gaagaactcg tcaagaaggc gatagaaggc gatgcgctgc gaatcgggag cggcgatacc 3240
gtaaagcacg aggaagcggt cagcccattc gccgccaagc tcttcagcaa tatcacgggt 3300
agccaacgct atgtcctgat agcggtccgc cacacccagc cggccacagt cgatgaatcc 3360
agaaaagcgg ccattttcca ccatgatatt cggcaagcag gcatcgccat gggtcacgac 3420
gagatcctcg ccgtcgggca tgctcgcctt gagcctggcg aacagttcgg ctggcgcgag 3480
cccctgatgc tcttcgtcca gatcatcctg atcgacaaga ccggcttcca tccgagtacg 3540
tgctcgctcg atgcgatgtt tcgcttggtg gtcgaatggg caggtagccg gatcaagcgt 3600
atgcagccgc cgcattgcat cagccatgat ggatactttc tcggcaggag caaggtgtag 3660
atgacatgga gatcctgccc cggcacttcg cccaatagca gccagtccct tcccgcttca 3720
gtgacaacgt cgagcacagc tgcgcaagga acgcccgtcg tggccagcca cgatagccgc 3780
gctgcctcgt cttgcagttc attcagggca ccggacaggt cggtcttgac aaaaagaacc 3840
gggcgcccct gcgctgacag ccggaacacg gcggcatcag agcagccgat tgtctgttgt 3900
gcccagtcat agccgaatag cctctccacc caagcggccg gagaacctgc gtgcaatcca 3960
tcttgttcaa tcatgcgaaa cgatcctcat cctgtctctt gatcagagct tgatcccctg 4020
cgccatcaga tccttggcgg cgagaaagcc atccagttta ctttgcaggg cttcccaacc 4080
ttaccagagg gcgccccagc tggcaattcc ggttcgcttg ctgtccataa aaccgcccag 4140
tctagctatc gccatgtaag cccactgcaa gctacctgct ttctctttgc gcttgcgttt 4200
tcccttgtcc agatagccca gtagctgaca ttcatccggg gtcagcaccg tttctgcgga 4260
ctggctttct acgtgctcga ggggggccaa acggtctcca gcttggctgt tttggcggat 4320
gagagaagat tttcagcctg atacagatta aatcagaacg cagaagcggt ctgataaaac 4380
agaatttgcc tggcggcagt agcgcggtgg tcccacctga ccccatgccg aactcagaag 4440
tgaaacgccg tagcgccgat ggtagtgtgg ggtctcccca tgcgagagta gggaactgcc 4500
aggcatcaaa taaaacgaaa ggctcagtcg aaagactggg cctttcgttt tatctgttgt 4560
ttgtcggtga acgctctcct gagtaggaca aatccgccgg gagcggattt gaacgttgcg 4620
aagcaacggc ccggagggtg gcgggcagga cgcccgccat aaactgccag gcatcaaatt 4680
aagcagaagg ccatcctgac ggatggcctt tttgcgtttc tacaaactct tttgtttatt 4740
tttctaaata cattcaaata tgtatccgct catgaccaaa atcccttaac gtgagttttc 4800
gttccactga gcgtcagacc ccgtagaaaa gatcaaagga tcttcttgag atcctttttt 4860
tctgcgcgta atctgctgct tgcaaacaaa aaaaccaccg ctaccagcgg tggtttgttt 4920
gccggatcaa gagctaccaa ctctttttcc gaaggtaact ggcttcagca gagcgcagat 4980
accaaatact gtccttctag tgtagccgta gttaggccac cacttcaaga actctgtagc 5040
accgcctaca tacctcgctc tgctaatcct gttaccagtg gctgctgcca gtggcgataa 5100
gtcgtgtctt accgggttgg actcaagacg atagttaccg gataaggcgc agcggtcggg 5160
ctgaacgggg ggttcgtgca cacagcccag cttggagcga acgacctaca ccgaactgag 5220
atacctacag cgtgagctat gagaaagcgc cacgcttccc gaagggagaa aggcggacag 5280
gtatccggta agcggcaggg tcggaacagg agagcgcacg agggagcttc cagggggaaa 5340
cgcctggtat ctttatagtc ctgtcgggtt tcgccacctc tgacttgagc gtcgattttt 5400
gtgatgctcg tcaggggggc ggagcctatg gaaaaacgcc agcaacgcgg cctttttacg 5460
gttcctggcc ttttgctggc cttttgctca catgttcttt cctgcgttat cccctgattc 5520
tgtggataac cgtattaccg cctttgagtg agctgatacc gctcgccgca gccgaacgac 5580
cgagcgcagc gagtcagtga gcgaggaagc ggaagagcgc ctgatgcggt attttctcct 5640
tacgcatctg tgcggtattt cacaccgcat atggtgcact ctcagtacaa tctgctctga 5700
tgccgcatag ttaagccagt atacactccg ctatcgctac gtgactgggt catggctgcg 5760
ccccgacacc cgccaacacc cgctgacgcg ccctgacggg cttgtctgct cccggcatcc 5820
gcttacagac aagctgtgac cgtctccggg agctgcatgt gtcagaggtt ttcaccgtca 5880
tcaccgaaac gcgcgaggca gcagatcaat tcgcgcgcga aggcgaagcg gcatgcataa 5940
tgtgcctgtc aaatggacga agcagggatt ctgcaaaccc tatgctactc cgtcaagccg 6000
tcaattgtct gattcgttac caattatgac aacttgacgg ctacatcatt cactttttct 6060
tcacaaccgg cacggaactc gctcgggctg gccccggtgc attttttaaa tacccgcgag 6120
aaatagagtt gatcgtcaaa accaacattg cgaccgacgg tggcgatagg catccgggtg 6180
gtgctcaaaa gcagcttcgc ctggctgata cgttggtcct cgcgccagct taagacgcta 6240
atccctaact gctggcggaa aagatgtgac agacgcgacg gcgacaagca aacatgctgt 6300
gcgacgctgg cgat 6314
<210> 3
<211> 2315
<212> DNA
<213>pMC- hNTCP micro-loop carrier for expression of eukaryon sequence
<400> 3
cccaactggg gtaacctttg ggctccccgg gcgcgactag tgaattcaga tctcccgatc 60
ccctatggtg cactctcagt acaatctgct ctgatgccgc atagttaagc cagtatctgc 120
tccctgcttg tgtgttggag gtcgctgagt agtgcgcgag caaaatttaa gctacaacaa 180
ggcaaggctt gaccgacaat tgcatgaaga atctgcttag ggttaggcgt tttgcgctgc 240
ttcgcgatgt acgggccaga tatacgcgtt gacattgatt attgactagt tattaatagt 300
aatcaattac ggggtcatta gttcatagcc catatatgga gttccgcgtt acataactta 360
cggtaaatgg cccgcctggc tgaccgccca acgacccccg cccattgacg tcaataatga 420
cgtatgttcc catagtaacg ccaataggga ctttccattg acgtcaatgg gtggagtatt 480
tacggtaaac tgcccacttg gcagtacatc aagtgtatca tatgccaagt acgcccccta 540
ttgacgtcaa tgacggtaaa tggcccgcct ggcattatgc ccagtacatg accttatggg 600
actttcctac ttggcagtac atctacgtat tagtcatcgc tattaccatg gtgatgcggt 660
tttggcagta catcaatggg cgtggatagc ggtttgactc acggggattt ccaagtctcc 720
accccattga cgtcaatggg agtttgtttt ggcaccaaaa tcaacgggac tttccaaaat 780
gtcgtaacaa ctccgcccca ttgacgcaaa tgggcggtag gcgtgtacgg tgggaggtct 840
atataagcag agctctctgg ctaactagag aacccactgc ttactggctt atcgaaatta 900
atacgactca ctatagggag acccaagctg gctagcgcca ccatggaggc ccacaacgcg 960
tctgccccat tcaacttcac cctgccaccc aactttggca agcgccccac agacctggca 1020
ctgagcgtca tcctggtgtt catgttgttc ttcatcatgc tctcgctggg ctgcaccatg 1080
gagttcagca agatcaaggc tcactttgga agcctaaagg gctggccatc gccctggtgg 1140
cacagtatgg catcatgccc ctcacggcct ttgtgctggg caaggtcttc cggctgaaga 1200
acattgaggc actggccatc ttggtctgtg gctgctcacc tggagggaac ctgtccaatg 1260
tcttcagtct ggccatgaag ggggacatga acctcagcat tgtgatgacc acctgctcca 1320
ccttctgtgc ccttggcatg atgcctctcc tcctgtacat ctactccagg gggatctatg 1380
atggggacct gaaggacaag gtgccctata aaggcatcgt gatatcactg gtcctggttc 1440
tcattccttg caccataggg atcgtcctca aatccaaacg gccacaatac atgcgctatg 1500
tcatcaaggg agggatgatc atcattctct tgtgcagtgt ggccgtcaca gttctctctg 1560
ccatcaatgt ggggaagagc atcatgtttg ccatgacacc actcttgatt gccacctcct 1620
ccctgatgcc ttttattggc tttctgctgg gttatgttct ctctgctctc ttctgcctca 1680
atggacggtg cagacgcact gtcagcatgg agactggatg ccaaaatgtc caactctgtt 1740
ccaccatcct caatgtggcc tttccacctg aagtcattgg accacttttc ttctttcccc 1800
tcctctacat gattttccag cttggagaag ggcttctcct cattgccata ttttggtgct 1860
atgagaaatt caagactccc aaggataaaa caaaaatgat ctacacagct gccacaactg 1920
aagaaacaat tccaggagct ctgggaaatg gcacctacaa aggggaggac tgctcccctt 1980
gcacagccac cgagacctcc caggtggcgc ccgcttagac cggtcatcat caccatcacc 2040
attgagttta aacccgctga tcagcctcga ctgtgccttc tagttgccag ccatctgttg 2100
tttgcccctc ccccgtgcct tccttgaccc tggaaggtgc cactcccact gtcctttcct 2160
aataaaatga ggaaattgca tcgcattgtc tgagtaggtg tcattctatt ctggggggtg 2220
gggtggggca ggacagcaag ggggaggatt gggaagacaa tagcaggcat gctggggatg 2280
cggtgggctc tatgggtcga cccatggggg cccgc 2315
Claims (3)
1. a kind of construction method for the mouse model for expressing people NTCP, which comprises the steps of:
S1. amplification obtains people's NTCP gene eucaryon expression frame;
S2. between the site attB and attP by people's NTCP gene eucaryon expression frame by molecule clone technology insertion plasmid ZY781,
Obtain the micro-loop parental plasmid ZY781-CMV-hNTCP of carrier's NTCP gene eucaryon expression frame;
S3. micro-loop parental plasmid ZY781-CMV-hNTCP is transferred toE.coliIn ZYCY10P3S2T competence, positive gram of screening
Grand, gained positive colony obtains the micro-loop of carrier's NTCP eukaryotic expression cassette after arabinose induction recombinase Ф C31 effect
DNApMC-CMV-hNTCP;
S4. it by minicircle dna by hydrodynamic coefficients method, imports in Mice Body and obtains gene transfection mouse, gene transfects mouse warp
PCR can be used as model use and correlative study after groupization detection and the detection of related biological index;
Wherein, the hydrodynamic coefficients method and step are as follows: the ICR mouse for choosing 6~8 weeks, 26~28g of weight carries 15 μ g
The minicircle dna of people's NTCP eukaryotic expression cassette is dissolved in 2.5ml physiological saline, and mouse is injected into 5~8s through mouse tail vein
In vivo.
2. the construction method of mouse model according to claim 1, which is characterized in that minicircle dna pMC-CMV- described in S3
The acquisition condition of hNTCP are as follows: 300 μ l micro-loop inductions are inoculated with the TB for containing 50 μ g/ml kanamycins into 50ml with mother liquor and are trained
In nutrient solution, 37 DEG C, 250 rpm/min cultivate 12~18h after, isometric induction liquid, 32 DEG C, 250 are added into culture solution
Rpm/min cultivates 5 h, receives bacterium, extracts minicircle dna;The induction liquid contains the LB culture solution of 50 ml, 2 ml 1N
20% L-arabinose of NaOH solution and 300 μ l.
3. construction method according to claim 2, which is characterized in that the micro-loop induces with mother liquor the preparation method comprises the following steps: parent
This plasmid ZY781-CMV-hNTCP conversionE.coliZYCY10P3S2T competence, the single positive colony of picking are inoculated into TB training
In nutrient solution, 37 DEG C, 250 rpm/min cultivate 15~18h to OD600When value is 4~5, it can be used as induction and lured with mother liquor
Minicircle dna is given birth in artificial delivery.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510211260.8A CN104862336B (en) | 2015-04-29 | 2015-04-29 | A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510211260.8A CN104862336B (en) | 2015-04-29 | 2015-04-29 | A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104862336A CN104862336A (en) | 2015-08-26 |
CN104862336B true CN104862336B (en) | 2018-12-18 |
Family
ID=53908510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510211260.8A Expired - Fee Related CN104862336B (en) | 2015-04-29 | 2015-04-29 | A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104862336B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111926041B (en) * | 2020-10-16 | 2020-12-25 | 广州吉妮欧生物科技有限公司 | SARS-CoV-2 pseudovirus mouse internal packaging system and its preparation method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311974A (en) * | 2010-07-05 | 2012-01-11 | 北京五加和分子医学研究所有限公司 | Recombinant adeno-associated virus-hepatitis B virus 1.3 (rAAV8-HBV1.3) for establishing HBV mouse model |
CN103898100A (en) * | 2012-12-26 | 2014-07-02 | 深圳先进技术研究院 | cccDNA standard substance, preparation method thereof, and method and kit for quantitatively detecting cccDNA of hepatitis B virus |
CN104096239A (en) * | 2014-01-10 | 2014-10-15 | 中国人民解放军第四五八医院 | Application of human augmenter of liver regeneration (hALR) genetic micro-ring eukaryotic expression vector in aspect of reducing liver collagen synthesis |
-
2015
- 2015-04-29 CN CN201510211260.8A patent/CN104862336B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102311974A (en) * | 2010-07-05 | 2012-01-11 | 北京五加和分子医学研究所有限公司 | Recombinant adeno-associated virus-hepatitis B virus 1.3 (rAAV8-HBV1.3) for establishing HBV mouse model |
CN103898100A (en) * | 2012-12-26 | 2014-07-02 | 深圳先进技术研究院 | cccDNA standard substance, preparation method thereof, and method and kit for quantitatively detecting cccDNA of hepatitis B virus |
CN104096239A (en) * | 2014-01-10 | 2014-10-15 | 中国人民解放军第四五八医院 | Application of human augmenter of liver regeneration (hALR) genetic micro-ring eukaryotic expression vector in aspect of reducing liver collagen synthesis |
Non-Patent Citations (3)
Title |
---|
An Immunocompetment mouse model for the tolerance of human chronic hepatitis B virus infection;Li-Rung Huang et al;《PNAS》;20061130;第103卷(第47期);摘要 * |
HBV life cycle is restricted in mouse hepatocytes expressing human NTCP;Hanjie Li,et al;《Cellular & Molecular Immunology》;20141231;摘要 * |
Minicirle DNA vectors Devoid of Bacterial DNA result in Presistent and High-level Transgene Expression in Vivo;ZhiYing-Chen et al;《Molecular Therapy》;20030930;第8卷(第3期);摘要,图1 * |
Also Published As
Publication number | Publication date |
---|---|
CN104862336A (en) | 2015-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6426208B1 (en) | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof | |
US6773920B1 (en) | Delivery of functional protein sequences by translocating polypeptides | |
KR101522217B1 (en) | Fsh producing cell clone | |
DK2713712T3 (en) | TRANSGEN CHICKEN, INCLUDING AN INACTIVATED IMMUNGLOBULIN GENE | |
CN108949693A (en) | A kind of pair of T cell immune detection point access carries out the method and application of gene knockout | |
CN110257425B (en) | A PS transposon system and its mediated gene transfer method | |
CN111850127A (en) | Application of NTNG1 protein in preparation of liver cancer diagnostic reagent or kit | |
CN110938651A (en) | Method and application of targeted targeting vector and targeted integration of foreign gene into mouse F4/80 exon 22 site to construct BAC clone | |
IL198421A (en) | Adipocyte-specific constructs for specifically inhibiting platelet-type 12 lipoxygenase expression and uses thereof | |
CN104862336B (en) | A kind of expression hepatitis B receptor --- construction method of the mouse model of people NTCP | |
US20010010928A1 (en) | Protozoan expression system | |
CN109929847B (en) | PEX26 gene, protein and application thereof | |
CN111893185A (en) | Construction method and application of cell strain expressing NTNG1 gene | |
KR20090119283A (en) | Improvement of Protein Overexpression System Using Green Fluorescent Protein | |
KR101535070B1 (en) | Recomnication expression vector of vascular growth factor and the vascular growth factor expressing stem cell line thereof | |
KR101446388B1 (en) | Transgenic animal expressing variant protein of preS1 W4P from HBV and its use | |
CN111100841B (en) | Establishment and application of genetically engineered cell lines and high-throughput drug screening models for anti-obesity drug target UCP1 | |
CN107805627B (en) | Construction method of hESC indicating cell line for specifically tracing endothelial cell differentiation | |
CN109735569B (en) | Trimolecule fluorescence complementary protein action receptor expression system and preparation method and application thereof | |
CN101679976A (en) | nucleic acids and libraries | |
CN110777147A (en) | IKZF3 gene-silenced T cell and application thereof | |
CN102051378A (en) | Method for screening anti-HIV-1 (Human Immunodeficiency Virus) drugs with virus mRNA core transfer as target point | |
CN116672442B (en) | Preparation of medicine for treating osteosarcoma by combining ligustilide and HER2-CAR-T cells | |
CN112852651B (en) | A kind of method for improving the yield of hydrocortisone produced by biotransformation of Saccharomyces cerevisiae | |
CN114231513B (en) | A Short Peptide Inhibiting the Activity of Proteasome PSMB5 Subunit and Its Application in Anti-Rickettsia Infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181218 Termination date: 20200429 |
|
CF01 | Termination of patent right due to non-payment of annual fee |